Managing infection in the critical care unit: How can infection control make the ICU safe?

Critical Care Clinics

Volumn 21, Issue 1, 2005, Pages 111-128

  Shulman, Lawrence ^a   Ost, David ^a,b  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMPHOTERICIN; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN; METICILLIN; METOCLOPRAMIDE; NAFCILLIN; PENICILLIN G; POLYMYXIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SUCRALFATE; TOBRAMYCIN; VANCOMYCIN;

BACTERIAL INFECTION; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG RESISTANCE; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; MEASUREMENT; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; RISK FACTOR; VENTILATOR;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS; PNEUMONIA; RESPIRATION, ARTIFICIAL; RISK FACTORS;

EID: 9644303221     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2004.10.002     Document Type: Review

References (69)

1. S.K. Fridkin, and R.P. Gaynes Antimicrobial resistance in intensive care units Clin Chest Med 20 2 1999 303 316
2. S.K. Fridkin, S.F. Welbel, and R.A. Weinstein Magnitude and prevention of nosocomial infections in the intensive care unit Infect Dis Clin North Am 11 2 1997 479 496
3. D.K. Warren, S.J. Shukla, and M.A. Olsen Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center Crit Care Med 31 5 2003 1312 1317
4. L. Papazian, F. Bregeon, and X. Thirion Effect of ventilator-associated pneumonia on mortality and morbidity Am J Respir Crit Care Med 154 1 1996 91 97
5. J. Chastre, and J.Y. Fagon Ventilator-associated pneumonia Am J Respir Crit Care Med 165 7 2002 867 903
6. J.L. Trouillet, J. Chastre, and A. Vuagnat Ventilator-associated pneumonia caused by potentially drug-resistant bacteria Am J Respir Crit Care Med 157 2 1998 531 539
7. National Nosocomial Infections Surveillance (NNIS) System Report Data summary from January 1990-May 1999 Am J Infect Control 27 6 1999 520 532
8. National Nosocomial Infections Surveillance (NNIS) System Report Data summary from January 1992 to June 2002 Am J Infect Control 30 8 2002 458 475
9. M.H. Kollef, G. Sherman, and S. Ward Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients Chest 115 2 1999 462 474
10. C.M. Luna, P. Vujacich, and M.S. Niederman Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia Chest 111 3 1997 676 685
11. F. Alvarez-Lerma Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group Intensive Care Med 22 5 1996 387 394
12. J. Rello, E. Quintana, and V. Ausina Incidence, etiology, and outcome of nosocomial pneumonia in mechanically ventilated patients Chest 100 2 1991 439 444
13. J. Rello, M. Gallego, and D. Mariscal The value of routine microbial investigation in ventilator-associated pneumonia Am J Respir Crit Care Med 156 1 1997 196 200
14. M.H. Kollef, and S. Ward The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia Chest 113 2 1998 412 420
15. M.J. Bonten, M.H. Kollef, and J.B. Hall Risk factors for ventilator-associated pneumonia: from epidemiology to patient management Clin Infect Dis 38 8 2004 1141 1149
16. H.R. Collard, S. Saint, and M.A. Matthay Prevention of ventilator-associated pneumonia: an evidence-based systematic review Ann Intern Med 138 6 2003 494 501
17. P. Dodek, S. Keenan, and D. Cook Evidence-based clinical practice guideline for the prevention of ventilator-associated pneumonia Ann Intern Med 141 4 2004 305 313
18. M.H. Kollef Ventilator-associated pneumonia. A multivariate analysis JAMA 270 16 1993 1965 1970
19. R. Celis, A. Torres, and J.M. Gatell Nosocomial pneumonia. A multivariate analysis of risk and prognosis Chest 93 2 1988 318 324
20. J. Rello, R. Sonora, and P. Jubert Pneumonia in intubated patients: role of respiratory airway care Am J Respir Crit Care Med 154 1 1996 111 115
21. A. Torres, R. Aznar, and J.M. Gatell Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients Am Rev Respir Dis 142 3 1990 523 528
22. J. Rello, J.A. Paiva, and J. Baraibar International Conference for the Development of Consensus on the Diagnosis and Treatment of Ventilator-associated Pneumonia Chest 120 3 2001 955 970
23. J. Rello, M. Sa-Borges, and H. Correa Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices Am J Respir Crit Care Med 160 2 1999 608 613
24. J. Baraibar, H. Correa, and D. Mariscal Risk factors for infection by Acinetobacter baumannii in intubated patients with nosocomial pneumonia Chest 112 4 1997 1050 1054
25. A. Messori, S. Trippoli, and M. Vaiani Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trials BMJ 321 7269 2000 1103 1106
26. K. Smulders, H. van der Hoeven, and I. Weers-Pothoff A randomized clinical trial of intermittent subglottic secretion drainage in patients receiving mechanical ventilation Chest 121 3 2002 858 862
27. A. Liberati, R. D'Amico, and S. Pifferi Antibiotics for preventing respiratory tract infections in adults receiving intensive care Cochrane Database Syst Rev 4 2000 CD000022
28. D. Cook, J.D. Ricard, and B. Reeve Ventilator circuit and secretion management strategies: a Franco-Canadian survey Crit Care Med 28 10 2000 3547 3554
29. E. de Jonge, M.J. Schultz, and L. Spanjaard Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial Lancet 362 9389 2003 1011 1016
30. J.M. Sirvent, and A. Torres Antibiotic prophylaxis strategies in the prevention of ventilator-associated pneumonia Expert Opin Pharmacother 4 8 2003 1345 1354
31. J.M. Sirvent, A. Torres, and M. El-Ebiary Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma Am J Respir Crit Care Med 155 5 1997 1729 1734
32. B. Quinio, J. Albanese, and M. Bues-Charbit Selective decontamination of the digestive tract in multiple trauma patients. A prospective double-blind, randomized, placebo-controlled study Chest 109 3 1996 765 772
33. C. Verwaest, J. Verhaegen, and P. Ferdinande Randomized, controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit Crit Care Med 25 1 1997 63 71
34. M. Sanchez Garcia, J.A. Cambronero Galache, and J. Lopez Diaz Effectiveness and cost of selective decontamination of the digestive tract in critically ill intubated patients. A randomized, double-blind, placebo-controlled, multicenter trial Am J Respir Crit Care Med 158 3 1998 908 916
35. M. Antonelli, G. Conti, and M. Rocco A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure N Engl J Med 339 7 1998 429 435
36. S. Nava, N. Ambrosino, and E. Clini Noninvasive mechanical ventilation in the weaning of patients with respiratory failure due to chronic obstructive pulmonary disease. A randomized, controlled trial Ann Intern Med 128 9 1998 721 728
37. J.M. Sanchez-Nieto, A. Torres, and F. Garcia-Cordoba Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator- associated pneumonia: a pilot study Am J Respir Crit Care Med 157 2 1998 371 376
38. D.E. Ost, C.S. Hall, and G. Joseph Decision analysis of antibiotic and diagnostic strategies in ventilator-associated pneumonia Am J Respir Crit Care Med 168 9 2003 1060 1067
39. J. Rello, M. Sa-Borges, and H. Correa Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices Am J Respir Crit Care Med 160 2 1999 608 613
40. J. Rello, V. Ausina, and M. Ricart Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia Chest 104 4 1993 1230 1235
41. J. Chastre, M. Wolff, and J.Y. Fagon Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial JAMA 290 19 2003 2588 2598
42. M.H. Kollef, S. Ward, and G. Sherman Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices Crit Care Med 28 10 2000 3456 3464
43. D.A. Goldmann, R.A. Weinstein, and R.P. Wenzel Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership JAMA 275 3 1996 234 240
44. J.L. Trouillet, A. Vuagnat, and A. Combes Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms Clin Infect Dis 34 8 2002 1047 1054
45. K.S. Kaye, S. Cosgrove, and A. Harris Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp Antimicrob Agents Chemother 45 9 2001 2628 2630
46. K.S. Kaye, J.J. Engemann, and H.S. Fraimow Pathogens resistant to antimicrobial agents: Epidemiology, molecular mechanisms, and clinical management Infect Dis Clin North Am 18 3 2004 467 511
47. D.M. Shlaes, D.N. Gerding, and J.F. John Jr Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals Clin Infect Dis 25 3 1997 584 599
48. S.K. Fridkin, C.D. Steward, and J.R. Edwards Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals Clin Infect Dis 29 2 1999 245 252
49. D.L. Monnet, L.K. Archibald, and L. Phillips Antimicrobial use and resistance in eight US hospitals: complexities of analysis and modeling. Intensive Care Antimicrobial Resistance Epidemiology Project and National Nosocomial Infections Surveillance System Hospitals Infect Control Hosp Epidemiol 19 6 1998 388 394
50. M. Graham Frequency and duration of handwashing in an intensive care unit Am J Infect Control 18 2 1990 77 81
51. D. Pittet, S. Hugonnet, and S. Harbarth Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme Lancet 356 9238 2000 1307 1312
52. D. Pittet, P. Mourouga, and T.V. Perneger Compliance with handwashing in a teaching hospital. Infection Control Program Ann Intern Med 130 2 1999 126 130
53. J. Wiener, J.P. Quinn, and P.A. Bradford Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes JAMA 281 6 1999 517 523
54. L.B. Rice, E.C. Eckstein, and J. DeVente Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center Clin Infect Dis 23 1 1996 118 124
55. J.J. Rahal, C. Urban, and D. Horn Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella JAMA 280 14 1998 1233 1237
56. P. Toltzis, T. Yamashita, and L. Vilt Antibiotic restriction does not alter endemic colonization with resistant gram-negative rods in a pediatric intensive care unit Crit Care Med 26 11 1998 1893 1899
57. D. Gruson, G. Hilbert, and F. Vargas Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria Am J Respir Crit Care Med 162 3 Pt 1 2000 837 843
58. M.H. Kollef, J. Vlasnik, and L. Sharpless Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia Am J Respir Crit Care Med 156 4 Pt 1 1997 1040 1048
59. M.H. Kollef, L. Sharpless, and J. Vlasnik The impact of nosocomial infections on patient outcomes following cardiac surgery Chest 112 3 1997 666 675
60. D.E. Ost, J. Gnanaraj, and C.S. Hall Comparison of physician vs neural network antibiotic selection in late onset ventilator associated pneumonia Am J Respir Crit Care Med 165 8 2002 A240
61. R.S. Evans, S.L. Pestotnik, and D.C. Classen A computer-assisted management program for antibiotics and other anti-infective agents N Engl J Med 338 4 1998 232 238
62. P.M. Dubbert, J. Dolce, and W. Richter Increasing ICU staff handwashing: effects of education and group feedback Infect Control Hosp Epidemiol 11 4 1990 191 193
63. B. Simmons, J. Bryant, and K. Neiman The role of handwashing in prevention of endemic intensive care unit infections Infect Control Hosp Epidemiol 11 11 1990 589 594
64. B.N. Doebbeling, G.L. Stanley, and C.T. Sheetz Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units N Engl J Med 327 2 1992 88 93
65. J. Kaye, V. Ashline, and D. Erickson Critical care bug team: a multidisciplinary team approach to reducing ventilator-associated pneumonia Am J Infect Control 28 2 2000 197 201
66. J.J. Schentag, C.H. Ballow, and A.L. Fritz Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division, and the microbiology laboratory Diagn Microbiol Infect Dis 16 3 1993 255 264
67. M. Farrington, C. Redpath, and C. Trundle Winning the battle but losing the war: methicillin-resistant Staphylococcus aureus (MRSA) infection at a teaching hospital QJM 91 8 1998 539 548
68. J.B. Thorens, R.M. Kaelin, and P. Jolliet Influence of the quality of nursing on the duration of weaning from mechanical ventilation in patients with chronic obstructive pulmonary disease Crit Care Med 23 11 1995 1807 1815
69. S.H. Woolf Patient safety is not enough: targeting quality improvements to optimize the health of the population Ann Intern Med 140 1 2004 33 36